Vanguard Group Inc Akero Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.57 Trillion
  • Q4 2024

A detailed history of Vanguard Group Inc transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,704,411 shares of AKRO stock, worth $166 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,704,411
Previous 3,676,581 0.76%
Holding current value
$166 Million
Previous $105 Million 2.3%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$26.75 - $35.28 $744,452 - $981,842
27,830 Added 0.76%
3,704,411 $103 Million
Q3 2024

Nov 13, 2024
SELL
$21.45 - $29.34 $611,518 - $836,454
-28,509 Reduced 0.77%
3,676,581 $105 Million
Q2 2024

Aug 13, 2024
BUY
$18.31 - $24.62 $643,907 - $865,811
35,167 Added 0.96%
3,705,090 $86.9 Million
Q1 2024

May 10, 2024
BUY
$17.76 - $31.18 $10.4 Million - $18.2 Million
584,875 Added 18.96%
3,669,923 $92.7 Million
Q4 2023

Feb 14, 2024
BUY
$11.38 - $50.33 $829,215 - $3.67 Million
72,866 Added 2.42%
3,085,048 $72 Million
Q3 2023

Nov 14, 2023
BUY
$41.19 - $52.25 $13.4 Million - $17 Million
326,308 Added 12.15%
3,012,182 $152 Million
Q2 2023

Aug 14, 2023
BUY
$36.89 - $56.88 $20.2 Million - $31.1 Million
546,981 Added 25.57%
2,685,874 $125 Million
Q1 2023

May 15, 2023
BUY
$37.27 - $50.24 $831,940 - $1.12 Million
22,322 Added 1.05%
2,138,893 $81.8 Million
Q4 2022

Feb 10, 2023
BUY
$33.44 - $54.8 $12.6 Million - $20.6 Million
375,978 Added 21.6%
2,116,571 $116 Million
Q3 2022

Nov 14, 2022
BUY
$10.15 - $34.05 $4.36 Million - $14.6 Million
429,579 Added 32.77%
1,740,593 $59.3 Million
Q2 2022

Aug 12, 2022
BUY
$8.0 - $15.01 $672,824 - $1.26 Million
84,103 Added 6.85%
1,311,014 $12.4 Million
Q1 2022

May 13, 2022
BUY
$12.97 - $22.26 $732,701 - $1.26 Million
56,492 Added 4.83%
1,226,911 $17.4 Million
Q4 2021

Feb 14, 2022
BUY
$19.87 - $26.24 $1.79 Million - $2.36 Million
89,834 Added 8.31%
1,170,419 $24.8 Million
Q3 2021

Nov 12, 2021
BUY
$18.65 - $25.46 $390,698 - $533,361
20,949 Added 1.98%
1,080,585 $24.2 Million
Q2 2021

Aug 13, 2021
BUY
$24.81 - $32.35 $26.3 Million - $34.3 Million
1,059,636 New
1,059,636 $26.3 Million

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.08B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email